| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||
Net Loss | ||||||||
-44,895 | -43,285 | -38,429 | -34,052 | -32,387 | -26,478 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Stock-based compensation | ||||||||
3,834 | 2,842 | 1,862 | 1,332 | 1,287 | 1,141 | 0 | 0 | 0 |
Change in fair value of warrant liability | ||||||||
- | - | - | - | - | 520 | 0 | 0 | 0 |
Amortization of premium and discounts on marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses and other current assets | ||||||||
790 | -2,367 | -742 | -159 | -1,541 | 2,396 | 0 | 0 | 0 |
Accounts payable | ||||||||
2,757 | 1,207 | 1,741 | 2,914 | -147 | 109 | 0 | 0 | 0 |
Accrued interest recievable | ||||||||
0 | - | - | - | - | - | - | - | - |
Accrued expenses | ||||||||
1,172 | 762 | 1,985 | 431 | 1,305 | 484 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||
-37,900 | -36,065 | -32,099 | -28,999 | -23,987 | -22,642 | 0 | 0 | 0 |
Investing activities | ||||||||
Purchase of marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Maturities of marketable securities | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash provided by in investing activities | ||||||||
0 | - | - | - | - | - | - | - | - |
Financing activities | ||||||||
Proceeds from issuance of common stock | ||||||||
0 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||||
0 | - | - | - | - | - | - | - | - |
Net decrease in cash and cash equivalents | ||||||||
-14,064 | -19,374 | 0 | 0 | 0 | - | - | - | - |
Net decrease in cash and cash equivalents | ||||||||
- | - | - | - | - | - | - | - | 0 |
Supplemental disclosure of non-cash financing transactions: | ||||||||
Accretion of Series A Convertible Redeemable Preferred Stock | ||||||||
- | - | - | - | - | - | - | 0 | 0 |